Table 3

Risk stratification of SMM

No. of risk factorsPatients, n (%)Progression at 5 years
Mayo Clinic criteria*   
 1 76 (28) 25% 
 2 115 (42) 51% 
 3 82 (30) 76% 
PETHEMA criteria**   
 0 28 (31) 4% 
 1 22 (25) 46% 
 2 39 (44) 72% 
No. of risk factorsPatients, n (%)Progression at 5 years
Mayo Clinic criteria*   
 1 76 (28) 25% 
 2 115 (42) 51% 
 3 82 (30) 76% 
PETHEMA criteria**   
 0 28 (31) 4% 
 1 22 (25) 46% 
 2 39 (44) 72% 
*

N = 27353,54 . Risk factors: (1) BMPCs >10%; (2) M-protein >3 g/L; and (3) FLC ratio <0.125 or >8.

**

N = 8955 . Risk factors: (1) ≥95% abnormal plasma cells, including decreased CD38 expression, expression of CD56, and absence of CD19 and/or CD45; and (2) immunoparesis.

Close Modal

or Create an Account

Close Modal
Close Modal